Stryker (SYK) EBIT (2009 - 2026)

Stryker (SYK) has 18 years of EBIT data on file, last reported at $936.0 million in Q1 2026.

• On a quarterly basis, EBIT rose 11.83% year-over-year to $936.0 million in Q1 2026; TTM through Mar 2026 was $5.0 billion, a 40.35% increase from a year earlier, with the FY2025 full-year figure at $4.9 billion, up 32.53% from the prior year.
• EBIT for Q1 2026 stood at $936.0 million, down from $1.8 billion in the prior quarter.
• Over the last five years, EBIT for SYK reached as high as $1.8 billion in Q4 2025 and fell as low as $447.0 million in Q1 2022.
• Historically, EBIT has averaged $955.5 million across 5 years, with a median of $936.0 million in 2026.
• Across the five-year window, EBIT sank 53.78% in 2024 and surged 210.5% in 2025, its largest moves.
• Year by year, EBIT stood at $814.0 million in 2022, then surged by 54.42% to $1.3 billion in 2023, then plunged by 53.78% to $581.0 million in 2024, then jumped by 210.5% to $1.8 billion in 2025, then slumped by 48.12% to $936.0 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $936.0 million in Q1 2026, $1.8 billion in Q4 2025, and $1.1 billion in Q3 2025.